To provide an overview of the medical literature on giant @entity438 ( @entity438 ).The PubMed, Medline, Google Scholar, and Google databases were searched using keywords to identify articles related to @entity438 . Keywords used were @entity438 , @entity432 , huge @entity438 , @entity1756 , and @entity438 . SAAs with a diameter >= 5cm are considered as giant and included in this study. The language of the publication was not a limitation criterion, and publications dated before January 15, 2015 were considered.The literature review included 69 papers (62 fulltext, 6 abstract, 1 nonavailable) on giant @entity438 . A sum of 78 @entity1 (50 males, 28 females) involved in the study with an age range of 27-87 years (mean    SD: 55.8  14.0 years). Age range for male was 30-87 (mean  SD: 57.5  12.0 years) and for female was 27-84 (mean  SD: 52.7  16.6 years). Most frequent predisposing factors were acute or chronic @entity788 , @entity731 , @entity101 , and @entity82 . @entity439 dimensions were obtained for 77 @entity1 with a range of 50-300mm (mean  SD: 97.1  46.0mm). @entity439 dimension range for females was 50-210mm (mean  SD: 97.5  40.2mm) and for males was 50-300mm (mean  SD: 96.9  48.9mm). Intraperitoneal/retroperitoneal @entity397 was present in 15, among which with a lesion dimension range of 50-180mm (mean  SD; 100  49.3mm) which was range of 50-300mm (mean  SD: 96.3  45.2mm) in cases without @entity397 . Mortality for @entity397 @entity1 was 33.3%. Other frequent complications were @entity292 (n=3), @entity292 (n=1), @entity3472 (n=1), @entity2548 (n=3), and portosplenic @entity292 (n=1). Eight of the @entity1 died in early postoperative period while 67 survived. Survival status of the remaining 3 @entity1 is unclear. Range of follow-up period for the surviving @entity1 varies from 3 weeks to 42 months.Either @entity397 or fistulization into hollow organs risk increase in compliance with @entity439 diameter. Mortality is significantly high in @entity397 cases. @entity1 with an evident risk should undergo either surgical or interventional radiological treatment without delay.

Management of Giant XXXX : Comprehensive Literature Review.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity788 :: ('MESH:D010190', 'Disease') :: ['pancreatitis'] @entity82 :: ('MESH:D005355', 'Disease') :: ['cirrhosis'] @entity101 :: ('MESH:D006973', 'Disease') :: ['hypertension'] @entity438 :: ('MESH:D002532', 'Disease') :: ['visceral artery aneurysm', 'splenic artery aneurysm', 'SAA'] @entity439 :: ('MESH:D000783', 'Disease') :: ['Aneurysm', 'aneurysm'] @entity397 :: ('MESH:D012421', 'Disease') :: ['rupture'] @entity292 :: ('MESH:D005402', 'Disease') :: ['colosplenic fistula', 'fistula', 'gastrosplenic fistula'] @entity3472 :: ('MESH:D010185', 'Disease') :: ['pancreatic fistula'] @entity432 :: ('MESH:D001157', 'Disease') :: ['giant splenic artery aneuryms'] @entity731 :: ('MESH:D050197', 'Disease') :: ['atherosclerosis'] @entity2548 :: ('MESH:D001164', 'Disease') :: ['splenic arteriovenous fistula'] @entity1756 :: ('MESH:D017542', 'Disease') :: ['splenic artery aneurysm rupture']
@entity438 :: (MESH:D002532,Disease) :: ['Splenic Artery Aneurysm']
